# HDS CDTR Administrative Core

> **NIH NIH P30** · KAISER FOUNDATION RESEARCH INSTITUTE · 2020 · $38,002

## Abstract

Diabetes mellitus is a significant health burden in the United States, affecting more than 20,000,000
people and costing more than $100 billion annually. The prevalence of Type 2 diabetes (T2DM) is growing
rapidly; the CDC estimates that up to 1/3 of Americans will have diabetes by the year 2050. The burden of
T2DM is particularly great among ethnic minority populations and those of lower socioeconomic status. The
evidence base for the prevention and care of T2DM is one of the most well-established of any chronic illness:
clinical trials have shown the efficacy of cardiometabolic therapies in preventing mortality and morbidity in
diabetes, and programs such as the Diabetes Prevention Program (DPP) have demonstrated that diabetes can
be prevented in high-risk patients. However, the overall quality of care for diabetes remains sub-optimal,
significant disparities in diabetes care and prevention persist, and there are very few effective populationbased
efforts to systematically reduce prevent diabetes and reduce diabetes risk. Programs that can effectively
translate high-quality, evidence-based diabetes prevention and treatment into widespread practice are
desperately needed.
In response to this need, diabetes researchers at the Kaiser Permanente Northern California Division of
Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the
University of California San Francisco (UCSF) created the Health Delivery Systems Center for Diabetes
Translational Research (HDS-CDTR) in 2011 (P30 DK092924). This CDTR fosters and supports translational
research in diabetes within health care delivery systems affiliated with the Health Care Systems Research
Network (formerly known as the HMO Research Network) and with UCSF. The HDS- CDTR brings together a
multi-disciplinary network of well-established investigators with a strong history of receiving federal and
foundation funding in diabetes translational research. The HDS-CDTR is structured around three Translational
Research Cores in the areas of health care disparities; diabetes and obesity prevention; and health information
technology. HDS-CDTR investigators have strong relationships with delivery systems, ranging from large
integrated delivery systems to networks of safety net providers that serve as key partners for translating
effective interventions into real-world clinical settings. Our CDTR will continue to be a strong resource to underresourced
delivery systems across the U.S. through its Resource Core, which will continue and expand our
support of these systems in their efforts to provide high quality diabetes prevention and care. In addition, the
HDS-CDTR is expanding its mission to address disparities through the creation of a new Core for Underserved
Populations that will develop a strong partnership with junior and senior Underrepresented Minority (URM)
investigators at the Morehouse School of Medicine.

## Key facts

- **NIH application ID:** 10016263
- **Project number:** 5P30DK092924-10
- **Recipient organization:** KAISER FOUNDATION RESEARCH INSTITUTE
- **Principal Investigator:** Julie A Schmittdiel
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $38,002
- **Award type:** 5
- **Project period:** 2011-09-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10016263

## Citation

> US National Institutes of Health, RePORTER application 10016263, HDS CDTR Administrative Core (5P30DK092924-10). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10016263. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*